leadf
logo-loader
viewSkye Bioscience inc

Skye Bioscience name change from Emerald Bioscience reflects 'limitless' strategy to treat glaucoma

Skye Bioscience, Inc. (OTCQB: SKYE) CEO Punit Dhillon tells Proactive the San Diego, California-based biopharmaceutical company has changed its name from Emerald Bioscience, Inc. to Skye Bioscience, Inc. Dhillon says the name change reflects how 'the sky is limitless' for the group's robust pipeline on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need.

Quick facts: Skye Bioscience inc

Price: 0.1095 USD

OTCQB:SKYE
Market: OTCQB
Market Cap: $27.38 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Loop Insights getting ready to rumble as platform wallet being used by the...

Loop Insights (CVE: MTRX- OTCQB: RACMF) CEO Rob Anson joined Steve Darling from Proactive with big news that Loop's Wallet pass platform will engage global boxing fans during the WBC super-middleweight championship fight, featuring champion Saul "Canelo" Alvarez and challenger Avni...

1 day, 21 hours ago

2 min read